Laura E. Niklason - President, CEO and Director, Director at Humacyte, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO and Director, Director
Stock Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Laura E. Niklason - trading volume in the past year for Humacyte, Inc.

Holdings reported by Laura E. Niklason for Humacyte, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 4,559,140 $33.3 M $7.30 Jun 12, 2024 By Ayabudge LLC
Common Stock 1,148,240 $8.38 M $7.30 Jun 11, 2024 By The Niklason Living Trust
Common Stock 510,161 $3.72 M $7.30 Jun 11, 2024 By spouse
Common Stock 240,832 $1.76 M $7.30 Jun 11, 2024 Direct
Stock Options (right to buy) 50,000 Jun 13, 2024 By spouse Common Stock

Transactions reported by Laura E. Niklason for Humacyte, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership